Skip to content
‹ Back to IndustriesHealthcare

The Future of Cancer Care and the Power of Patient Voices

What trends today will kick off a new age for oncology practices? Madelyn Trupkin Herzfeld, CEO for Carevive, which is building technologies that improve the cancer patient treatment experience and survival outcomes while lowering costs, shared her thoughts and insights. With the pandemic adding layers of complexity to the already challenging world of cancer…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share
The Future of Cancer Care and the Power of Patient Voices

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

What trends today will kick off a new age for oncology practices? Madelyn Trupkin Herzfeld, CEO for Carevive, which is building technologies that improve the cancer patient treatment experience and survival outcomes while lowering costs, shared her thoughts and insights.

With the pandemic adding layers of complexity to the already challenging world of cancer care, Herzfeld said it wasn’t easy for healthcare providers to add new technology solutions during this time.

“What you’ve heard most about is patients fearing coming in for screenings,” Herzfeld said. “So diagnostic testing and new cancer cases certainly haven’t been identified, because patients have said they are going to put the screening off until after the pandemic.”

One trend coming out of the pandemic is virtual consultations, which Herzfeld believes will continue long after COVID-19.

“Virtual care is finding the right use cases in all areas of healthcare, but particularly in cancer care, where it’s possible to do follow up consults virtually,” Herzfeld said. “You won’t see that go away when the pandemic ends.”

Carevive’s solutions focus on patient-reported outcomes, and Herzfeld shared her excitement on the evolution of cancer care in this area and the many improvements to come.

“Making sure that we understand what the patient is experiencing, what their symptoms are and how can we get in front of them to make the best quality of life when patients have advanced cancer,” Herzfeld said. “So that is taking front and center stage with all stakeholders in the cancer care industry.”

One of the things Carevive is doing to help make cancer treatment better is remote patient monitoring.

“Providers need a scalable technology to do remote patient monitoring, which is a positive thing we’re able to provide them,” Herzfeld said. “We’re also able to provide them with the insights from their data that can really help them improve their practice, improve the treatments they select for patients and improve their symptom management practices.”

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

AdvaMed approves voluntary data access best practices for medtech companies and health systems

AdvaMed approves voluntary data access best practices for medtech companies and health systems

AdvaMed's Digital Health Tech board approved voluntary Data Access Principles & Best Practices, announced October 28, setting four principles for how medtech companies and U.S. health systems share data.

  • 01The framework covers data vendors need to implement, monitor and improve technology, with expectations for transparency, stewardship and de-identification.
  • 02Watch for the first RFPs, security questionnaires or data use agreements that cite the principles by name; a voluntary document gains weight only when buyers adopt it.

Nov 5, 2026

Nearly 500 hospitals track shortage-affected segments via RFID

Nearly 500 hospitals track shortage-affected segments via RFID

According to Bluesight, nearly 500 hospitals track almost 4,000 shortage-affected medication segments in their RFID systems. Checks of dispensing cabinets have been missing that RFID-tracked supply. Gilman argues that bringing RFID data in next to cabinet data gives more complete usage rates and days-on-hand calculations, though the gain could depend on whether systems connect at the transaction level.

  • 01During a shortage, a count that stops at the dispensing cabinet can misstate both stock on hand and usage rate, creating a false sense of urgency and wasteful emergency purchases.
  • 02RFID is no longer limited to kit and tray management: nearly 500 hospitals already track almost 4,000 shortage-affected medication segments in their RFID systems.
  • 03For operators weighing a merged feed, the key question could be whether RFID usage flows into the days-on-hand calculation at the transaction level or sits beside cabinet data as a static count.

Nov 4, 2026

New York City digital health startups raised $1.9 billion in Q3, up 36%

New York City digital health startups raised $1.9 billion in Q3, up 36%

New York City digital health startups raised $1.9 billion in Q3 2026, up 36% year over year. Nationally, Rock Health counted $3.7 billion raised by U.S. digital health startups across 114 deals in the quarter. Bigger checks and steady acquisitions mean buyers must assess which vendors are pulling ahead—and which may change owners mid-rollout.

  • 01New York's digital health startups grew Q3 funding 36% year over year, while U.S. digital health startups raised $3.7 billion across 114 deals in Q3, according to Rock Health.
  • 02Average U.S. digital health deal size has climbed from $20.6 million in 2024 to $31.0 million so far in 2026, so more of the money is going into bigger rounds.
  • 03Most ownership changes are happening through M&A, with 164 deals through Q3 2026 and no new public listings since August 2025. That makes vendor change-of-ownership a live contract concern for buyers.

Nov 4, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512